V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20193514 | 20169945 | null | null | Adjuvant (A) | 2019-07-15 | 2019-07-25 | null | 02 | N | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 100967649 |
| 20193552 | 20169946 | 1.69 | 104 | 03 | 2019-12-02 | 2019-12-08 | MIC | 02 | N | ECF | 100636346 |
| 20193638 | 20169947 | 1.79 | 59.55 | null | 2019-02-28 | 2019-12-23 | SCOPE 2 TRIAL | 02 | N | CARFILZOMIB | 101825471 |
| 20193764 | 20169948 | 1.7 | 60 | null | 2018-08-08 | 2018-08-08 | CHOP R - 21 days | 99 | null | MELPHALAN | 100878145 |
| 20193816 | 20169949 | 1.97 | 65.2 | Palliative (P) | 2019-11-21 | 2019-11-22 | FOCUS4 TRIAL | 02 | N | VINORELBINE | 100567206 |
| 20194172 | 20169950 | null | null | Palliative (P) | 2017-12-23 | 2017-12-26 | Binimetinib + Encorafenib | 02 | null | CISPLATIN + FLUOROURACIL + RT | 100352389 |
| 20194445 | 20169951 | 1.84 | 69.9 | Palliative (P) | 2018-02-04 | 2018-02-05 | Gemcitabine + Oxaliplatin | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100408192 |
| 20194533 | 20169952 | 1.49 | 125.2 | Neo-adjuvant (N) | 2016-12-13 | 2017-12-05 | CARBOPLATIN + FLUOROURACIL + Trastuzumab | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100062470 |
| 20194746 | 20169953 | 1.77 | 76.8 | Curative (C) | 2016-01-22 | 2016-12-02 | CAM-PLEX Trial | 02 | null | PACLITAXEL + RAMUCIRUMAB | 101348927 |
| 20194882 | 20169954 | 1.8 | 64 | null | 2020-07-05 | 2020-07-11 | Durvalumab | 02 | null | CAV | 100175880 |
| 20195081 | 20169955 | null | 22.8 | Disease modification (D) | null | 2019-03-29 | CT7001 | null | Y | BACILLUS CALMETTE-GUERIN | 100873840 |
| 20195682 | 20169956 | null | 17.2 | 03 | 2018-06-18 | 2018-06-30 | EEF or EOF | 02 | null | CARBOPLATIN + RALTITREXED | 100723794 |
| 20197298 | 20169957 | 1.58 | 59 | Neo-adjuvant (N) | 2020-06-29 | 2020-06-29 | BENDAMUSTINE + RITUXIMAB | N | N | CAPECITABINE + STREPTOZOCIN | 101227674 |
| 20197652 | 20169958 | 1.86 | 62.2 | null | 2018-06-03 | 2018-08-04 | IBRUTINIB | 02 | N | TEMOZOLOMIDE | 101151692 |
| 20197694 | 20169959 | 1.83 | 69.2 | null | 2018-12-22 | 2020-04-25 | CAV | 02 | N | CNS ATRT VCA VINC/DACTINO/CYCLOPHOS | 100150951 |
| 20197771 | 20169960 | 1.75 | 19.5 | Palliative (P) | 2019-07-28 | 2019-08-04 | Epirubicin | 02 | null | BACILLUS CALMETTE-GUERIN | 101740973 |
| 20198126 | 20169961 | 1.53 | 55.1 | Adjuvant (A) | 2017-05-08 | 2021-01-02 | Paclitaxel albumin (Abraxane) 21day | N | N | ERIBULIN | 100341536 |
| 20198192 | 20169962 | 1.54 | 53.4 | Palliative (P) | 2019-10-28 | 2019-10-28 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | OXALIPLATIN + MDG + PANITUMUMAB | 100980667 |
| 20198502 | 20169963 | 1.76 | 115.9 | null | 2018-05-18 | 2018-05-24 | CAM-PLEX Trial | 02 | null | ECARBOX | 100826449 |
| 20198916 | 20169964 | 0 | 65.2 | null | 2021-08-10 | 2021-08-17 | R-CHOEP | 02 | null | SCOPE 1 TRIAL | 100498854 |
| 20199648 | 20169965 | 1.5 | null | 03 | 2017-03-10 | 2020-02-05 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | N | FLUOROURACIL + OXALIPLATIN + TRASTUZUMAB | 100122884 |
| 20199729 | 20169966 | 2 | 87.4 | 03 | 2020-06-09 | 2020-06-28 | MELPHALAN | null | N | LIPOSOMAL DAUNORUBICIN + LIPOSOMAL CYTARABINE (VYXEOS) | 100995507 |
| 20200205 | 20169967 | 1.72 | 115.9 | null | 2020-11-06 | 2020-11-06 | Carboplatin + Fluorouracil + Streptozocin | 02 | null | ECARBOX | 100355560 |
| 20200367 | 20169968 | 1.72 | 78.1 | null | 2016-08-16 | 2016-08-16 | Olaparib | 02 | null | TOPOTECAN | 101569823 |
| 20200379 | 20169969 | 1.7 | 109 | null | 2022-02-26 | 2022-03-26 | CAV | 01 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101544874 |
| 20200823 | 20169970 | 1.81 | 77.6 | Palliative (P) | 2018-10-26 | 2018-11-06 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | CISPLATIN + RT | 100337471 |
| 20201166 | 20169971 | null | null | Palliative (P) | 2018-10-10 | 2018-11-25 | Bortezomib + Daratumumab | 02 | N | BUSULPHAN | 100687744 |
| 20201314 | 20169972 | 1.6 | 81.55 | Palliative (P) | 2018-09-20 | 2018-09-22 | CAPECITABINE + MITOMYCIN + RT | 02 | N | CISPLATIN + FLUOROURACIL + RT | 101256435 |
| 20201351 | 20169973 | 1.71 | 118.6 | Disease modification (D) | 2020-04-08 | 2020-05-06 | FCarboSt | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100065020 |
| 20201824 | 20169974 | 1.42 | 56.1 | null | 2018-10-14 | 2018-10-17 | FLUOROURACIL + OXALIPLATIN + Trastuzumab | 02 | N | BEVACIZUMAB + FLUOROURACIL + IRINOTECAN | 100763172 |
| 20202435 | 20169976 | 1.71 | 57 | Neo-adjuvant (N) | 2021-05-17 | 2021-06-29 | Temozolomide + RT | 02 | N | DOCETAXEL + GEMCITABINE | 101699061 |
| 20202543 | 20169977 | 1.58 | 81.7 | Neo-adjuvant (N) | 2018-02-03 | 2018-02-03 | Carboplatin + Liposomal Doxorubicin | 02 | null | ETOPOSIDE | 100765754 |
| 20202716 | 20169978 | 1.89 | 75.5 | null | 2021-03-24 | 2021-03-24 | Rituximab | 02 | null | TCH | 100129577 |
| 20203204 | 20169980 | 0 | 64.15 | Neo-adjuvant (N) | 2021-01-26 | 2021-02-02 | Capecitabine + Streptozocin | N | N | OBINUTUZUMAB | 101602500 |
| 20203627 | 20169981 | 1.71 | 75.9 | null | 2022-01-13 | 2022-01-19 | SCOPE 2 TRIAL | 02 | N | CABOZANTINIB | 101042890 |
| 20203679 | 20169982 | 1.52 | 85 | null | 2020-01-06 | 2020-01-09 | Brentuximab | 02 | null | CARBOPLATIN + VINORELBINE | 101039595 |
| 20203844 | 20169983 | 1.8 | null | null | 2022-02-01 | 2022-03-01 | TEMOZOLOMIDE | 02 | N | DABRAFENIB + TRAMETINIB | 100156914 |
| 20204002 | 20169984 | 1.69 | 95.65 | null | 2019-07-01 | 2019-12-26 | R GCVP | 02 | null | GEMCITABINE + OXALIPLATIN | 101176113 |
| 20204380 | 20169986 | 1.58 | 62.4 | null | 2019-11-04 | 2019-11-05 | Rituximab | 02 | null | CAPE + OXALIPLATIN + TRASTUZUMAB | 100099922 |
| 20204408 | 20169987 | null | null | Palliative (P) | 2017-05-21 | 2018-04-21 | FCarboSt | N | N | CISPLATIN + PEMETREXED | 101403143 |
| 20204423 | 20169988 | 1.71 | 71.6 | 03 | 2021-07-09 | 2021-07-09 | CAPECITABINE + LOMUSTINE | 02 | N | TOPOTECAN | 100383333 |
| 20204510 | 20169990 | 1.77 | 63.8 | Palliative (P) | 2021-09-21 | 2021-11-02 | Cisplatin +FU +Trastuzumab - Load | 02 | null | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 101478155 |
| 20204955 | 20169991 | 1.6 | 86.5 | 02 | null | 2022-05-16 | CHOP R - 21 days | null | N | DOXORUBICIN | 100856300 |
| 20205252 | 20169992 | 1.6 | null | Curative (C) | 2021-06-15 | 2021-06-26 | CAP + RT | 2 | N | CAPECITABINE + STREPTOZOCIN | 101853630 |
| 20205393 | 20169993 | 1.65 | 68.5 | Palliative (P) | 2019-09-10 | 2019-11-25 | Capecitabine + Streptozocin | 02 | N | CYTARABINE | 100502456 |
| 20205425 | 20169994 | 0.7 | null | Palliative (P) | 2016-08-07 | 2016-12-16 | Cisplatin +FU +Trastuzumab - Maint | 02 | N | FLUOROURACIL + RT | 101035569 |
| 20205674 | 20169995 | 1.98 | 46 | Curative (C) | 2019-11-28 | 2019-12-30 | Doxorubicin + Olaratumab | 02 | N | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 101791858 |
| 20205829 | 20169997 | 1.55 | 56.2 | Palliative (P) | 2016-11-10 | 2019-02-11 | FLUOROURACIL + Panitumumab | N | Y | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101085882 |
| 20206048 | 20169999 | 1.71 | null | 03 | 2019-11-28 | 2019-11-29 | Temozolomide + RT | 99 | N | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 101257517 |
| 20206119 | 20170000 | 1.77 | 71.1 | Palliative (P) | null | 2018-01-23 | CAP + RT | 1 | null | CISPLATIN + RT | 100637538 |